genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
Bacterial pneumonia
Drug Discovery
FDA Rejects NDAs for Cempra Bacterial Pneumonia Candidate Solithromycin
Drug Discovery
The Medicines Company Wins Up to $132M from BARDA Toward New Antibiotics
Drug Discovery
Cepheid, MedImmune Join COMBACTE in Antibacterial Diagnostics Collaboration
Drug Discovery
Bacterial Toxins Decoyed, Captured by Artificial Liposomes
Insights
Tissue Proteomics for the Next Decade? Toward a Molecular Dimension in Histology
Drug Discovery
Gene Discovery Points to Safer, More Effective Strep Vaccine
Drug Discovery
New Hope for Better Vaccines against Meningitis and Pneumonia
Insights
Metagenomics May Hold Key to Novel Antibiotic Discovery
Drug Discovery
MRSA-Battling Antibiotic to Take on Pneumonia in Europe
Drug Discovery
ZMC Nabs Chinese Rights to TaiGen’s Late-Stage Antibiotic for $8M
1
2
3
4
Page 2 of 4
Scroll Up